March 9, 2021

$ANPC AnPac Bio-Medical Science Evaluates New Cancer Detection Sensor

ANPC stock rose in pre-market trading on new cancer detection sensor. AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and

Biotechnology

February 16, 2021

$SESN Sesen Bio Stock Soars In Pre-market On FDA Priority Review

SESN stock rose more than 9% in pre-market trading on February 16, 2021, after the company announced that it has received priority review from the FDA for its Vicineum. Sesen Bio

Biotechnology

February 11, 2021

$MNPR Monopar Therapeutics Soars 55% In Pre-market

MNPR stock soared more than 55% in pre-market trading on February 11, 2021, after the company announced the publication of a peer-reviewed study in the European Journal of Cancer which

Biotechnology

February 10, 2021

$BPTH Bio-Path Stock Soars 100% In Pre-market

BPTH stock soared more than 100% in pre-market trading on February 10, 2021, after the company received a patent. Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal

Biotechnology

February 8, 2021

$ARYA ARYA Sciences SPAC With Nautilus Biotechnology

ARYA stock is moving higher in early trade on February 8, 2021, after the company announced a SPAC with Nautilus Biotechnology. Nautilus Biotechnology, Inc. ("Nautilus Biotechnology" or “Nautilus”), a company pioneering

Analysts Activity

Biotechnology

February 7, 2021

$OCGN Ocugen Stock Surged 64% In After-hours Trading

OCGN stock surged 64% in after-hours trading on February 5, 2021, after an analyst said to buy the stock. On February 4, 2021, H.C. Wainwright analyst Swayampakula Ramakanth upgraded Ocugen to

Biotechnology

February 3, 2021

$CLNN Clene Stock Soars More Than 100% On Buy Rating

CLNN stock soared more than 100% on February 3, 2021, after Roth Capital analyst Elemer Piros initiated coverage of Clene with a Buy rating and $24 price target. Roth Capital analyst

Biotechnology

Coronavirus

February 3, 2021

$TYME Tyme Technologies Granted U.S. Patent to Treat COVID-19 Infections

TYME stock soared more than 50% in pre-market trading after the company was granted a patent for its COVID-19 treatment. Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer

Biotechnology

January 25, 2021

$VYNE VYNE Therapeutics Up On Major PBM for AMZEEQ and ZILXI

VYNE stock rose in morning trade on January 25, 2021, after the company announced a major new deal. On January 21, 2021, VYNE Therapeutics Inc. (Nasdaq: VYNE) announced the execution of

Biotechnology

January 21, 2021

$IBIO iBio Stock Surges 16% In After-hours

IBIO stock surged 16% in after-hours trading on January 21, 2021, after the company received positive analyst coverage. Cantor Fitzgerald analyst Kristen Kluska initiated coverage of iBio with an Overweight rating

« Older Articles